NZ552040A - Veterinary formulation comprising an anthelmintic compound and glyceryl acetate - Google Patents

Veterinary formulation comprising an anthelmintic compound and glyceryl acetate

Info

Publication number
NZ552040A
NZ552040A NZ552040A NZ55204006A NZ552040A NZ 552040 A NZ552040 A NZ 552040A NZ 552040 A NZ552040 A NZ 552040A NZ 55204006 A NZ55204006 A NZ 55204006A NZ 552040 A NZ552040 A NZ 552040A
Authority
NZ
New Zealand
Prior art keywords
formulation
solvent
levamisole
glyceryl acetate
macrocyclic lactone
Prior art date
Application number
NZ552040A
Other languages
English (en)
Inventor
Karthigeyan Nanjan
Alawi Fadil Al
Original Assignee
Bomac Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomac Research Ltd filed Critical Bomac Research Ltd
Priority to NZ552040A priority Critical patent/NZ552040A/en
Priority to BRPI0720102-8A priority patent/BRPI0720102A2/pt
Priority to AU2007332222A priority patent/AU2007332222C1/en
Priority to PCT/NZ2007/000360 priority patent/WO2008072985A2/en
Publication of NZ552040A publication Critical patent/NZ552040A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ552040A 2006-12-13 2006-12-13 Veterinary formulation comprising an anthelmintic compound and glyceryl acetate NZ552040A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
NZ552040A NZ552040A (en) 2006-12-13 2006-12-13 Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
BRPI0720102-8A BRPI0720102A2 (pt) 2006-12-13 2007-12-13 Formulação de deposição
AU2007332222A AU2007332222C1 (en) 2006-12-13 2007-12-13 Pour on formulation
PCT/NZ2007/000360 WO2008072985A2 (en) 2006-12-13 2007-12-13 Pour on formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ552040A NZ552040A (en) 2006-12-13 2006-12-13 Veterinary formulation comprising an anthelmintic compound and glyceryl acetate

Publications (1)

Publication Number Publication Date
NZ552040A true NZ552040A (en) 2009-04-30

Family

ID=39512205

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ552040A NZ552040A (en) 2006-12-13 2006-12-13 Veterinary formulation comprising an anthelmintic compound and glyceryl acetate

Country Status (4)

Country Link
AU (1) AU2007332222C1 (pt)
BR (1) BRPI0720102A2 (pt)
NZ (1) NZ552040A (pt)
WO (1) WO2008072985A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011027333A1 (en) 2009-09-07 2011-03-10 Douglas Robert Cleverly Granulated anthelmintic preparations and delivery systems
AR081970A1 (es) * 2010-06-24 2012-10-31 Intervet Int Bv Formulacion inyectable de una lactona macrociclica y levamisol, formulacion y uso veterinario
JP6120834B2 (ja) 2011-06-23 2017-04-26 バイエル・ニュージーランド・リミテッド 大環状ラクトンおよびレバミゾールを含む抗寄生生物性組成物、ならびに寄生生物感染の処置方法
FR2991173B1 (fr) * 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
WO2014132227A1 (en) * 2013-02-27 2014-09-04 Batt Laurie Robert Transdermal formulations
CN103432152A (zh) * 2013-08-22 2013-12-11 潍坊富邦药业有限公司 一种驱杀家畜体内、外寄生虫的注射液及制备工艺
NZ701697A (en) * 2014-03-24 2016-05-27 Donaghys Ltd Stable veterinary anthelmintic formulations
EP3393455B1 (en) * 2015-12-22 2021-07-21 Intervet International B.V. Injectable formulation of a macrocyclic lactone and levamisole

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596586B2 (en) * 1985-04-30 1990-05-10 American Cyanamid Company Chemical derivatives of antibiotics S541
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
NZ335166A (en) * 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
DK0535734T3 (da) * 1991-09-30 1999-08-09 Merck & Co Inc Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie
DE69432982T2 (de) * 1993-05-10 2004-04-15 Merck & Co., Inc. Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden
IL136313A (en) * 1997-12-03 2005-08-31 Merck & Co Inc Long acting injectable formulations containing hydrogenated castor oil
CN1263435C (zh) * 1998-03-19 2006-07-12 麦克公司 控制释放生物活性物质的液态聚合物组合物
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
CN1421199A (zh) * 2001-11-29 2003-06-04 王玉万 采用微粉结晶法制备含抗寄生虫药物的兽用油悬注射剂
CN1444925A (zh) * 2002-03-19 2003-10-01 王玉万 含乙基纤维素的兽用长效注射制剂
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
CN1698636A (zh) * 2004-05-17 2005-11-23 王玉万 兽用抗寄生虫制剂的混用方法

Also Published As

Publication number Publication date
AU2007332222C1 (en) 2014-06-26
WO2008072985A3 (en) 2008-08-28
AU2007332222A1 (en) 2008-06-19
AU2007332222B2 (en) 2013-01-17
BRPI0720102A2 (pt) 2014-07-08
WO2008072985A2 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
AU2007332222B2 (en) Pour on formulation
EP1299108B1 (en) A parasiticidal formulation and a method of making this formulation
AU2001236949A1 (en) A parasiticidal formulation and a method of making this formulation
KR20130130762A (ko) 글리코푸롤을 포함하는 국소 적용 이속사졸린 제제
CN108055825A (zh) 包含异噁唑啉活性剂的延长释放可注射制剂、其方法和用途
US10449179B2 (en) Stable veterinary anthelmintic formulations
AU2003281472B2 (en) Levamisole, avermectins or similar in pyrrolidone solvent
KR20080073700A (ko) 벤즈이미다졸 비수성 조성물
ES2846820T3 (es) Composición de lactonas macrocíclicas, levamisol, un aminoazúcar y un agente antiparasitario adicional
US8653128B1 (en) Veterinary composition and method
EP2836199B1 (en) Fulvestrant formulations
AU2006100661B4 (en) Topical formulation
JP2021507891A (ja) 抗寄生生物性ポアオン組成物
EP3595441B1 (en) Stable topical veterinary composition
EP4230203A1 (en) Microsuspension against parasites and method for obtaining same
NZ535644A (en) Anthelmintic formulations
KR20140136005A (ko) 지속성 조성물
EA042495B1 (ru) Стабильная ветеринарная композиция для местного применения
BR102013017846A2 (pt) Nanoformulações e submicroformulações com ativos ultraconcentrados com dendrímeros a base de antiespasmódicos e/ou aines (anti-inflamatórios não hormonais) e/ou anti-histamínicos ou aies (anti-inflamatórios hormonais) e/ou ciclosporinas com a finalidade de redimir sintomas de inflamações, cólicas, pruridos e dor em bovinos, suínos, caprinos, ovinos, caninos e felinos ou benzoil uréia e/ou acil uréia e/ou avermectinas isoladamente ou combinada com vermífugo e/ou inseticidas para o controle e prevenção de endo e ectoparasitas em bovinos, suínos, caprinos, ovinos, caninos, felinos e aves
AU2013204176A1 (en) Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: BAYER NEW ZEALAND LIMITED, NZ

Free format text: OLD OWNER(S): BOMAC RESEARCH LIMITED

S883 Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant)

Free format text: CORRECTION TO SPECIFICATION (51)

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 NOV 2017 BY JAMES + WELLS

Effective date: 20140906

Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 15 NOV 2027 BY JAMES + WELLS

Effective date: 20140906

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 NOV 2020 BY JAMES + WELLS

Effective date: 20140906

ASS Change of ownership

Owner name: ELANCO NEW ZEALAND SIMPSON GRIERSON, NZ

Effective date: 20210707